AnalystsJeet MukherjeeJeet Mukherjee's Stock Forecasts
AnalystsJeet Mukherjee
Sectors:
Industries:
Analyst Ranking
Top 37%
#1883 out of 5069 analysts
Average Return
+14.37%
Win Rate
63%5 out of 8
Risk vs Reward
Poor
Good
Jeet Mukherjee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | +78.34% | $44.93 | $80.13 | 2025-09-09 - 2025-10-17 | Strong Buy |
Monopar TherapeuticsMNPR | +47.05% | $54.49 | $80.13 | 2025-09-15 - 2025-10-17 | Strong Buy |
Kymera Therapeutics IncKYMR | +32.81% | $45.05 | $59.83 | 2024-12-10 - 2025-10-17 | Strong Buy |
Arvinas IncARVN | +23.32% | $7.72 | $9.52 | 2025-09-18 - 2025-10-17 | Strong Buy |
Monopar TherapeuticsMNPR | +3.47% | $77.44 | $80.13 | 2025-09-25 - 2025-10-17 | Strong Buy |
Jeet Mukherjee Analyst Color
Get additional color on Jeet Mukherjee's coverage of popular stocks
Jeet Mukherjee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Perspective Therapeutics IncCATX | 2 | Strong Buy | $14.00 | +211.80% | Reiterates | 6 days ago |
Monopar TherapeuticsMNPR | 3 | Strong Buy | $104.00 | +29.79% | Maintains | 24 days ago |
Arvinas IncARVN | 1 | Strong Buy | $10.00 | +5.04% | Maintains | a month ago |
Nurix Therapeutics IncNRIX | 1 | Strong Buy | $35.00 | +255.69% | Initiates Coverage On | 10 months ago |
Kymera Therapeutics IncKYMR | 1 | Strong Buy | $60.00 | +0.28% | Initiates Coverage On | 10 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.